drugset / Trial / NCT00181142
The Use of Daclizumab and Anti-Thymocyte Globulin in Lung Transplantation
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare outcomes in patients undergoing lung transplantation, using 2 different induction therapies. Primary outcome is survival and secondary outcomes include freedom from infection and freedom from rejection.
Timeline
- Start
- 1999-10
- Primary completion
- 2004-12
- Completion
- 2004-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Daclizumab | Monoclonal antibody | — | — |
Indications
No indication recorded.